February 28, 2022
GHTC joins letters to European leaders calling for increased investment in TB R&D
Read time: 9 minutes
PATH/Georgina Goodwin
Ahead of the 6th Global Forum on TB Vaccines, GHTC joined call-to-action letters to European leaders calling for them to increase national investments in tuberculosis (TB) R&D, including TB vaccine R&D, in line with global fair share targets.
Tags: Advocacy action